Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison
出版年份 2016 全文链接
标题
Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison
作者
关键词
-
出版物
BMJ Open
Volume 6, Issue 2, Pages e009122
出版商
BMJ
发表日期
2016-02-24
DOI
10.1136/bmjopen-2015-009122
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
- (2013) Christopher Chapple et al. EUROPEAN UROLOGY
- Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
- (2013) Khaled Maman et al. EUROPEAN UROLOGY
- Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
- (2013) V. W. Nitti et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A phase II dose-ranging study of mirabegron in patients with overactive bladder
- (2013) Christopher R. Chapple et al. INTERNATIONAL UROGYNECOLOGY JOURNAL
- The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials
- (2013) Yuanshan Cui et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
- (2013) Sender Herschorn et al. UROLOGY
- New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
- (2013) Karl-Erik Andersson Therapeutics and Clinical Risk Management
- Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)
- (2012) Douglas G. Tincello et al. EUROPEAN UROLOGY
- Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
- (2012) Christopher R. Chapple et al. EUROPEAN UROLOGY
- Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial
- (2012) Vik Khullar et al. EUROPEAN UROLOGY
- Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
- (2012) E. Ann Gormley et al. JOURNAL OF UROLOGY
- OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
- (2012) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Results of a Randomized Phase III Trial of Mirabegron in Patients with Overactive Bladder
- (2012) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence
- (2012) Anthony G. Visco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
- (2012) Georgia Salanti Research Synthesis Methods
- Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study
- (2011) Pierre Denys et al. EUROPEAN UROLOGY
- Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China
- (2011) Yuliang Wang et al. NEUROUROLOGY AND URODYNAMICS
- EAU Guidelines on Urinary Incontinence
- (2010) Joachim W. Thüroff et al. EUROPEAN UROLOGY
- Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial
- (2010) Roger Dmochowski et al. JOURNAL OF UROLOGY
- Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review
- (2010) Randall K. Leong et al. UROLOGIA INTERNATIONALIS
- Reviewing the ICS 2002 terminology report: The ongoing debate
- (2009) Paul Abrams et al. NEUROUROLOGY AND URODYNAMICS
- Refractory Idiopathic Urge Urinary Incontinence and Botulinum A Injection
- (2008) Linda Brubaker et al. JOURNAL OF UROLOGY
- Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units
- (2008) Brian L. Cohen et al. NEUROUROLOGY AND URODYNAMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now